The cluster of director and CFO open-market purchases at $26-27 is a credible bullish signal, especially given the board's insider knowledge of pipeline progress. The CEO's small sale is likely liquidity-driven and does not offset the buying cluster. Monitor for upcoming clinical catalysts or earnings that may have prompted this coordinated buying. The 95% analyst bullish consensus supports the positive read.
Price Chart
Executive Summary
A cluster of insider purchases at Rapport Therapeutics, Inc. (RAPP) shows five directors and the CFO buying a total of ~$1.57M in open-market transactions over two days (Oct 21-22), while the CEO sold $64K. The buying is concentrated at prices between $26.10 and $27.28, with director Steven M. Paul alone purchasing $974K. This is a strong bullish signal from the board and CFO, partially offset by the CEO's small sale. The total buy value represents ~0.13% of the $1.2B market cap, which is modest in proportionality but amplified by the cluster nature and C-suite participation.
Key Financial Metrics
Key Facts
- Five directors and the CFO purchased a combined ~$1.57M in open-market transactions on Oct 21-22, 2026
- Director Steven M. Paul made the largest purchase: 35,714 shares at $27.28 for $974,278
- CEO Abraham Ceesay sold 2,210 shares at $29.16 for $64,448 on Oct 21
- Total insider buying represents ~0.13% of RAPP's $1.2B market cap
- The cluster is concentrated in a 2-day window, suggesting coordinated conviction
- RAPP has 95% analyst bullish consensus (18 Buy, 1 Hold)
Financial Impact
Total insider purchases of ~$1.57M represent 0.13% of market cap; CEO sale of $64K is negligible
Risk Factors
- CEO's concurrent sale, though small, introduces a note of caution
- Total buy value is modest relative to market cap (0.13%)
- Biotech stock volatility could overwhelm the signal from these purchases
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RAPP-1792787487122 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | Insider Cluster | $26.00 | awaiting T+5 | — | $25.93 (−0.27%) |
Oct 22, 2026 4d ago | Insider Cluster | $27.33 | awaiting T+5 | — | $25.93 (−5.12%) |
Oct 21, 2026 4d ago | Insider Buy | $26.53 | awaiting T+5 | — | $25.93 (−2.26%) |
Oct 20, 2026 6d ago | 8-K | $29.37 | awaiting T+5 | — | $25.93 (−11.71%) |
Oct 6, 2026 19d ago | 144 | $30.86 $28.33 | ▲ +8.20% | ▲ +7.22% | $25.93 (+15.98%) |
Oct 1, 2026 24d ago | Insider Cluster | $32.17 $30.65 | ▼ −4.72% | ▼ −5.89% | $25.93 (−19.40%) |
Aug 26, 2026 8w ago | Insider Cluster | $50.83 $47.65 | ▼ −6.26% | ▼ −6.52% | $25.93 (−48.99%) |
Aug 5, 2026 11w ago | 8-K | $42.44 $47.73 | ▲ +12.46% | ▲ +12.11% | $25.93 (−38.90%) |
Jul 1, 2026 16w ago | Insider Cluster | $38.97 $41.75 | ▲ +7.13% | ▲ +5.77% | $25.93 (−33.46%) |
Jun 30, 2026 16w ago | 144 | $39.39 $39.72 | ▲ +0.84% | ▲ +0.58% | $25.93 (−34.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers